文献
J-GLOBAL ID:201902279333772888
整理番号:19A0176497
新しい化学構造と異常な作用様式を持つアイソフォーム選択性ATAD2化学プローブ【JST・京大機械翻訳】
Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of Action
著者 (35件):
Fernandez-Montalvan Amaury E.
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Berger Markus
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Kuropka Benno
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Koo Seong Joo
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Badock Volker
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Weiske Joerg
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Puetter Vera
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Holton Simon J.
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Stoeckigt Detlef
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
ter Laak Antonius
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Centrella Paolo A.
(X-Chem Pharmaceuticals, Massachusetts, United States)
,
Clark Matthew A.
(X-Chem Pharmaceuticals, Massachusetts, United States)
,
Dumelin Christoph E.
(X-Chem Pharmaceuticals, Massachusetts, United States)
,
Sigel Eric A.
(X-Chem Pharmaceuticals, Massachusetts, United States)
,
Soutter Holly H.
(X-Chem Pharmaceuticals, Massachusetts, United States)
,
Troast Dawn M.
(X-Chem Pharmaceuticals, Massachusetts, United States)
,
Zhang Ying
(X-Chem Pharmaceuticals, Massachusetts, United States)
,
Cuozzo John W.
(X-Chem Pharmaceuticals, Massachusetts, United States)
,
Keefe Anthony D.
(X-Chem Pharmaceuticals, Massachusetts, United States)
,
Roche Didier
(Edelris, France)
,
Rodeschini Vincent
(Edelris, France)
,
Chaikuad Apirat
(Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, United Kingdom)
,
Chaikuad Apirat
(Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, United Kingdom)
,
Diaz-Saez Laura
(Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, United Kingdom)
,
Diaz-Saez Laura
(Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, United Kingdom)
,
Bennett James M.
(Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, United Kingdom)
,
Bennett James M.
(Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, United Kingdom)
,
Fedorov Oleg
(Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, United Kingdom)
,
Fedorov Oleg
(Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, United Kingdom)
,
Huber Kilian V. M.
(Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, United Kingdom)
,
Huber Kilian V. M.
(Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, United Kingdom)
,
Huebner Jan
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Weinmann Hilmar
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Hartung Ingo V.
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
,
Gorjanacz Matyas
(Bayer AG, Pharmaceuticals, Drug Discovery, Germany)
資料名:
ACS Chemical Biology
(ACS Chemical Biology)
巻:
12
号:
11
ページ:
2730-2736
発行年:
2017年
JST資料番号:
W5037A
ISSN:
1554-8937
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)